Cargando…
Efficacy of Liraglutide in a Real-Life Cohort
INTRODUCTION: In the Liraglutide Effect and Action in Diabetes (LEAD) randomized clinical trials (RCTs) assessing liraglutide in type 2 diabetes mellitus (T2DM), glycated hemoglobin (A1c) was reduced by 7–16 mmol/mol and weight by up to 3.4 kg. As real-life efficacy data on liraglutide is limited, t...
Autores principales: | Heymann, Anthony, Maor, Yasmin, Goldstein, Inbal, Todorova, Lora, Schertz-Sternberg, Perlit, Karasik, Avraham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065284/ https://www.ncbi.nlm.nih.gov/pubmed/24664620 http://dx.doi.org/10.1007/s13300-014-0062-2 |
Ejemplares similares
-
Erratum to: Efficacy of Liraglutide in a Real-Life Cohort
por: Heymann, Anthony, et al.
Publicado: (2014) -
A Retrospective Database Study of Liraglutide Persistence Associated with Glycemic and Body Weight Control in Patients with Type 2 Diabetes
por: Melzer-Cohen, Cheli, et al.
Publicado: (2019) -
Liraglutide-Induced Hepatotoxicity
por: Maor, Yaakov, et al.
Publicado: (2021) -
Marked weight loss on liraglutide 3.0 mg: Real‐life experience of a Swiss cohort with obesity
por: Santini, Sara, et al.
Publicado: (2022) -
Use of Healthcare Services Following Severe Hypoglycemia in Patients with Diabetes: Analysis of Real-World Data
por: Goldstein, Dalit, et al.
Publicado: (2016)